Second-Line Treatment of mCRC: Rechallenging Therapy
The role of molecular assays, including liquid biopsies, in providing information on resistance mechanisms in metastatic colorectal cancer and the impact of testing results on decisions for rechallenging with a previous therapy.
Read More